首页> 外文期刊>Cancer epidemiology >Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients
【24h】

Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients

机译:骨肉瘤中p53,c-MYC,BCL-2和凋亡指数的表达及其与患者预后的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Nowadays it remains a controversial issue whether a correlation exists between the apoptosis rate of tumor tissue and the prognosis of the patients. The aim of the study is to investigate the relationships of apoptotic genes and apoptotic index of osteosarcoma tissue to prognosis of the patients, meanwhile to explore the valid prognostic biomarkers of osteosarcoma that will enhance efficacy of clinical treatments for osteosarcoma. Methods: In our studies, the immunohistochemical ABC and terminal DNA breakpoints in situ 3-hydroxy end labeling (TUNEL) techniques were used to detect the expressions of p53, c-MYC, BCL-2 and apoptotic index in 56 osteosarcoma specimens. The relationships between apoptotic genes expression and apoptotic index in osteosarcoma tissue and their correlations with pathologic classification and prognosis of osteosarcoma cases were analyzed. Results: We found that the expressions of p53, c-MYC, and BCL-2 were negatively correlated with apoptotic index of osteosarcoma tissue, were not correlated with pathological types of osteosarcoma, and were closely related to prognosis of the patients. Moreover, apoptotic index of osteosarcoma tissue was positively correlated with the long term survival of the patients. Conclusion: We concluded that the expressions of p53, c-MYC, BCL-2 protein and apoptotic index could be used as potential biomarks for predicting the progression and prognosis of osteosarcoma, and for optimizing clinical treatments.
机译:背景:如今,肿瘤组织的凋亡率与患者的预后之间是否存在相关性仍是一个有争议的问题。本研究的目的是探讨骨肉瘤组织的凋亡基因和凋亡指数与患者预后的关系,同时探讨骨肉瘤的有效预后生物标志物,以提高骨肉瘤临床治疗的疗效。方法:在我们的研究中,采用免疫组织化学ABC和末端DNA断裂原位3-羟基末端标记(TUNEL)技术检测56例骨肉瘤样本中p53,c-MYC,BCL-2的表达和凋亡指数。分析了骨肉瘤组织中凋亡基因表达与凋亡指数的关系及其与骨肉瘤病理分类和预后的关系。结果:我们发现p53,c-MYC和BCL-2的表达与骨肉瘤组织的凋亡指数呈负相关,与骨肉瘤的病理类型无关,并且与患者的预后密切相关。此外,骨肉瘤组织的凋亡指数与患者的长期存活呈正相关。结论:我们得出结论,p53,c-MYC,BCL-2蛋白的表达和凋亡指数可作为预测骨肉瘤进展和预后以及优化临床治疗的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号